Wednesday, 24 May 2017

Korea News

  • Linagliptin efficacy further established in specific patient populations

    Korea |  News | By Nandita Singh | 0 Comment

    Seoul: Boehringer Ingelheim and Eli Lilly & Company have announced new data that reinforces the efficacy and tolerability of linagliptin in patients with Type 2 Diabetes (T2D) and liver...Read more

  • Boehringer Ingelheim, Hanmi to co-develop lung cancer drug

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Boehringer Ingelheim and Korea's Hanmi Pharmaceutical have collaborated for the development and global commercialisation rights, except South Korea, China and Hong Kong, of HM617...Read more

  • South Korea, EU join hands for bio-nano research

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: In a bid to boost its biotech and nanotechnology sectors, South Korea has inked a $80 million pact with the European Union (EU) to leverage EU's capabilities in science technolog...Read more

  • CrystalGenomics partners with Dong-A for Acelex commercialization

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Korea based CrystalGenomics has signed a sales and marketing agreement with Dong-A ST for the commercialization of Acelex (polmacoxib) in Korea. Acelex is a tissue-selective, on...Read more

  • Samsung progresses on RA biosilimar drug ph 3 trial

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Korea pharma giant, Samsung Bioepis, has successfully completed Phase 3 clinical study of SB5, an investigational biosimilar of Humira (adalimumab)for treating rheumatoid arthrit...Read more

  • Vigilant Biosciences enters Korea's oral cancer market

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Vigilant Biosciences, developer of early detection and intervention technology for oral cancer, has entered into a five-year exclusive sales and marketing distribution agreement ...Read more

  • Dong-A Pharma diversifies portfolio to include biosimilars

    Korea |  Analysis | By Amrita Tejasvi | 0 Comment

    Clocking revenues of $995.40 million, Dong-A pharmaceutical is acknowledged as a leading name in Korea's pharmaceutical industry. Over the years, the company has built alliances with inte...Read more

  • Samsung to construct a new drug manufacturing plant

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Samsung BioLogics, biologic drug-manufacturing arm of Samsung Group said that it would invest 850 billion Korean won ($740 million) to construct a new biologic drug manufacturing...Read more

  • BioElectronics enters Korean pain relief market

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: BioElectronics, the maker of unique pain relief, inexpensive, patented, consumer medical devices, begun product distribution of its ActiPatch Musculoskeletal Pain Relief, Allay M...Read more

  • Asia an emerging hotspot in medical tourism

    Korea |  Analysis | By Aishwarya Venkatesh | 0 Comment

    Singapore: BioSpectrum feels the pulse of Asia's top destinations and major players in medical tourism.  Medical tourism industry is growing worldwide. Frost and Sullivan predicts that t...Read more

  • Korean Shin Poong and French LFB set up JV

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: South Korean drugmaker, Shin Poong Pharmaceutical, and France's Laboratoire francais du Fractionnement et des Biotechnologies (LFB) signed a term sheet for setting up a joint ven...Read more

  • Green Cross to expand biologics market in Russia

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Korea based biopharmaceutical company, Green Cross, has partnered with Nanolek, a Russian pharmaceutical company, for the commercialisation of Green Cross' biologics in the Russi...Read more

  • China surpasses Korea in sci-tech competitiveness

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: A report published on February 11 by the Hyundai Economic Research Institute titled, 'Comparison of Korea-China Science Technology Competitiveness', has highlighted that China's ...Read more

  • Samsung eyes Nasdaq listing to raise cash

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Korean drugmaker Samsung Bioepis has declared plans to list on Nasdaq with eyes on raising cash to manufacture and market cheaper copies of blockbuster biologics. Mr Yang Chul-b...Read more

  • Korean companies lag behind in new drug research: Report

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Korean pharmaceutical companies were found to be lagging behind in new product development, according to a new report released by B2Pharm's Green List Alert service, which publis...Read more

  • Korea's ImmunoMet raises $5.2 mn

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Korea based ImmunoMet Therapeutics, a biotechnology company developing innovative drugs for the treatment of cancer, has raised $5.2 million in a Series A financing led by Mirae ...Read more

  • Green Cross builds biopharmaceutical facility in Canada

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Korea's Green Cross Biotherapeutics has started the construction of its biopharmaceutical facility located on the Montreal Technoparc's Saint-Laurent Campus. The $215 million pr...Read more

  • Soon, detect water contamination by smelling it!

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Korean scientists are developing a new bio-electronic device that can detect bacteria in water by smelling it without the need for complex equipment and testing. The study, publ...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls